DEUTSCHE BANK AG\

Holdings History for Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

Symbol: NRIX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.02%	+0.01%	$47,174,444	2,486,792	+1,047,933	+73%	$18.97	Q4 2025
30 Sep 2025	0%	+0%	$13,295,057	1,438,859	+1,069,981	+290%	$9.24	Q3 2025
30 Jun 2025	0%	-0%	$4,201,520	368,878	-11,270	-3%	$11.39	Q2 2025
31 Mar 2025	0%	-0%	$4,516,158	380,148	-151,049		$11.88	Q1 2025
31 Dec 2024	0%	-0%	$10,007,751	531,197	-323,485		$18.84	Q4 2024
30 Sep 2024	0.01%	-0%	$19,204,704	854,682	-193,712		$22.47	Q3 2024
30 Jun 2024	0.01%	-0%	$21,879,983	1,048,394	-450,974		$20.87	Q2 2024
31 Mar 2024	0.01%	+0.01%	$22,040,710	1,499,368	+995,163	+100%	$14.70	Q1 2024
31 Dec 2023	0%	+0%	$5,203,396	504,205	+484,610	+2473%	$10.32	Q4 2023
30 Sep 2023	0%	+0%	$154,017	19,595	+3,841	+24%	$7.86	Q3 2023
30 Jun 2023	0%	-0%	$157,382	15,754	-12,659	-45%	$9.99	Q2 2023
31 Mar 2023	0%	+0%	$252,308	28,413	+8,667	+44%	$8.88	Q1 2023
31 Dec 2022	0%	+0%	$216,811	19,746	+310	+1.6%	$10.98	Q4 2022
30 Sep 2022	0%	-0%	$253,000	19,436	-1,527	-7.3%	$13.02	Q3 2022
30 Jun 2022	0%	+0%	$266,000	20,963	+3,011	+17%	$12.69	Q2 2022
31 Mar 2022	0%	-0%	$252,000	17,952	-2,018	-10%	$14.04	Q1 2022
31 Dec 2021	0%	+0%	$578,000	19,970	+677	+3.5%	$28.94	Q4 2021
30 Sep 2021	0%	-0%	$578,000	19,293	-582	-2.9%	$29.96	Q3 2021
30 Jun 2021	0%	+0%	$527,000	19,875	+4,130	+26%	$26.52	Q2 2021
31 Mar 2021	0%	+0%	$490,000	15,745	+2,709	+21%	$31.12	Q1 2021
31 Dec 2020	0%	+0%	$429,000	13,036	+7,105	+120%	$32.91	Q4 2020
30 Sep 2020	0%	+0%	$207,000	5,931	+5,931	NEW	$34.90	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.